Skip to main content

Principles of Antimicrobial Drug Action

  • Chapter
Antimicrobial Drug Action
  • 50 Accesses

Abstract

The drugs which are active against microbial growth are of two types: those produced by micro-organisms, classed as antibiotics,and those which are synthetic. The antibiotics form the largest group and these may be defined as substances which, produced by micro-organisms, inhibit the growth of or kill other microorganisms. Even this is not a completely satisfactory definition since some microorganisms produce enzymes which are secreted extracellularly which can kill other cells, and other organisms produce protein factors which also can kill cells, for example the colicins, the killer factors of yeast and the kappa particles of Paramecium. Most antibiotics are secondary metabolites. These are substances which are produced at the end of the growth phase of micro-organisms in situations when the cells have stopped dividing (see figure 2.1).

Secondary metabolite (antibiotic) production during the growth phase of micro-organisms. The stippled area represents the zone of secondary metabolite production. A indicates the lag phase; B indicates the logarithmic or exponential phase; C indicates the stationary phase; D indicates the death phase.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

2.7 References and Further Reading

  • Ames, B. N. and Hooper, K. (1978). Does carcinogenic potency correlate with mutagenic potency in the Ames assay? Nature, Lond., 274, 19–20

    Article  Google Scholar 

  • Ames, B. N., McCann, J. and Yamasaki, E. (1975). Mutation Res., 31, 347–64

    Article  Google Scholar 

  • Ames, B. N. Durston, W. E., Yamasaki, E. and Lee, F. D. (1973). Carcinogens are mutagens. A simple test system combining liver homogenates for activation and bacteria for detection. Proc. Nat. Acad. Sci. U.S.A., 70, 2281–5

    Article  Google Scholar 

  • Ashby, J. and Styles, J. A. (1978a). Does carcinogenic potency correlate with mutagenic potency in the Ames assay? Nature, Lond., 271, 452–5

    Article  Google Scholar 

  • Ashby, J. and Styles, J. A. (1978b). Factors influencing mutagenic potency in vitro. Nature, Lond., 274, 20–2

    Article  Google Scholar 

  • Cundliffe, E. (1978). Mechanism of resistance to thiostrepton in the producer organism Streptomyces azureus. Nature, Lond., 272, 792–5

    Article  Google Scholar 

  • DeFlora, S. (1978). Metabolic deactivation of mutagens in the Salmonella-microsome test. Nature, Lond., 271, 455–6

    Article  Google Scholar 

  • Fuska, J. and Proska, D. (1976). Cytotoxic and antitumour antibiotics produced by micro-organisms. Adv. appl. Microbiol., 20, 259–370

    Article  Google Scholar 

  • Hewitt, W. (1977). Microbiological Assay-An Introduction to Quantitative Principles and Evaluation. Academic Press, London

    Google Scholar 

  • Kavanagh, F. (1963/72). Analytical Microbiology. Academic Press, London, Vol.1 (1963), Vol.2 (1972)

    Google Scholar 

  • Meselson, M. and Russell, K. (1977). In Origins of Human Cancer. (H. H. Hiatt, J. D. Watson and J. A. Winston eds), Cold Spring Harbor Publications, New York, pp. 1473–82

    Google Scholar 

  • Schubert, J. (1970). Formation of cell growth inhibition by chemicals and environmental agents. J. gen. Microbiol., 64, 37–40

    Article  Google Scholar 

  • Zähner, H. and Maas, W. K. (1972). Biology of Antibiotics. Springer-Verlag, Berlin, Heidelburg and New York

    Book  Google Scholar 

Download references

Authors

Copyright information

© 1980 David Edwards

About this chapter

Cite this chapter

Edwards, D. (1980). Principles of Antimicrobial Drug Action. In: Antimicrobial Drug Action. Palgrave, London. https://doi.org/10.1007/978-1-349-16360-1_2

Download citation

Publish with us

Policies and ethics